October 20, 2025 – Thanks to feedback from experts in the field, the team at Transplant Genomics announces a change to our existing reporting for Eurofins TRAC™ ID. These updates are designed to focus on the most pertinent and needed information for your kidney transplant recipients.

What’s Changing?

Enhanced ID Panel Reporting

The Infectious Disease (ID) panel will now appear on a separate page
Results will be reported in log10 (genomic copies/mL), expressed in the report as log(gC/mL)
Results for TTV will be reported with updated thresholds of 4.5 and 7.8 respectively, as per the September 2025 paper released titled Using Torque Teno Virus as a Serial Monitoring Tool for the Net State of Immunosuppression of Kidney Transplant Recipients. We encourage you to read the full paper here.

Virus Categorization for Clinical Insight

Viruses in the ID panel are now grouped into two clinically relevant categories
- Primary Transplant Viruses: Includes CMV, BKV, and EBV – viruses with established management guidelines for transplant patients
- Potential Biomarker: Includes TTV – a non-pathogenic virus currently under investigation for its potential role as a biomarker of immunosuppression

These changes will be taking effect as of 10/27/2025.

If you have any questions or require further assistance, please contact your client services representative at +1 844-878-4723 Thank you for your continued trust in Eurofins Transplant Genomics.

Warm Regards,

The Eurofins Transplant Genomics Team